NEW YORK (GenomeWeb) – Molecular diagnostics firm Paradigm announced today that it has signed a deal under which its PCDx next-generation sequencing-based cancer test will be covered by health insurer Three Rivers Provider Network.

According to Paradigm, Three Rivers has more than 15 million US members.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.